- Home
- SUPN vs ZGN Comparison
SUPN vs ZGN Comparison
Compare SUPN & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- ZGN
- Stock Information
- Founded
- SUPN 2005
- ZGN 1910
- Country
- SUPN United States
- ZGN Italy
- Employees
- SUPN N/A
- ZGN N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- ZGN Apparel
- Sector
- SUPN Health Care
- ZGN Consumer Discretionary
- Exchange
- SUPN Nasdaq
- ZGN Nasdaq
- Market Cap
- SUPN 2.6B
- ZGN 2.1B
- IPO Year
- SUPN 2012
- ZGN N/A
- Fundamental
- Price
- SUPN $46.13
- ZGN $9.67
- Analyst Decision
- SUPN Buy
- ZGN Buy
- Analyst Count
- SUPN 2
- ZGN 3
- Target Price
- SUPN $43.00
- ZGN $9.03
- AVG Volume (30 Days)
- SUPN 656.6K
- ZGN 783.2K
- Earning Date
- SUPN 11-03-2025
- ZGN 09-05-2025
- Dividend Yield
- SUPN N/A
- ZGN 1.47%
- EPS Growth
- SUPN 1411.53
- ZGN N/A
- EPS
- SUPN 1.14
- ZGN 0.43
- Revenue
- SUPN $665,125,000.00
- ZGN $2,248,050,499.00
- Revenue This Year
- SUPN $4.84
- ZGN N/A
- Revenue Next Year
- SUPN $17.69
- ZGN $4.69
- P/E Ratio
- SUPN $39.96
- ZGN $22.26
- Revenue Growth
- SUPN 5.55
- ZGN N/A
- 52 Week Low
- SUPN $29.16
- ZGN $6.05
- 52 Week High
- SUPN $46.79
- ZGN $9.99
- Technical
- Relative Strength Index (RSI)
- SUPN 64.12
- ZGN 72.85
- Support Level
- SUPN $43.44
- ZGN $8.70
- Resistance Level
- SUPN $46.72
- ZGN $9.40
- Average True Range (ATR)
- SUPN 1.13
- ZGN 0.26
- MACD
- SUPN -0.39
- ZGN 0.10
- Stochastic Oscillator
- SUPN 80.30
- ZGN 97.96
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.